Anpario plc, together with its subsidiaries, manufactures and distributes animal feed additives for animal health, nutrition, and biosecurity in the Americas, Asia, Europe, the Middle East, and Africa. The company offers animal gut health products, such as phytogenic and acid based eubiotics, and…more
Anpario plc, together with its subsidiaries, manufactures and distributes animal feed additives for animal health, nutrition, and biosecurity in the Americas, Asia, Europe, the Middle East, and Africa. The company offers animal gut health products, such as phytogenic and acid based eubiotics, and…more
Latest RNS from Anpario plc
- investor_eventInvestor Presentation via Investor Meet Company
- interim_resultsInterim Results
Analyst consensus: Buy
As of 21 Sept 2026, 2 analysts rate Anpario plc a Buy, with 100% buy ratings and a mean price target of 613p (range 600p–626p), +26% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 537p against a current price of 485p (+11%), based on EV/EBITDA.